Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts

Area of Science:

• Cell Biology
• Bone Biology
• Molecular Biology

Background:

• Osteoclast differentiation is crucial for bone remodeling and homeostasis.
• Protein phosphatase 2A catalytic subunit alpha (PP2A Cα) is implicated in various cellular processes.
• The role of PP2A Cα in osteoblasts and its influence on osteoclastogenesis remains unclear.

Purpose of the Study:

• To investigate the involvement of PP2A Cα expression in osteoblasts in the process of osteoclast differentiation.
• To elucidate the molecular mechanisms by which PP2A Cα in osteoblasts affects osteoclastogenesis.

Main Methods:

• Osteoblast cell line MC3T3-E1 was used with reduced PP2A Cα expression (shPP2A).
• Expression levels of receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin (OPG) were analyzed.
• Conditioned medium from shPP2A cells was used to treat bone marrow macrophage cells.
• Osteoclast differentiation markers, including NFATc1, cathepsin K, and osteoclast-associated receptor (OSCAR), were assessed.

Main Results:

• Reduction of PP2A Cα in osteoblasts led to decreased RANKL and increased OPG expression.
• Conditioned medium from PP2A Cα-reduced osteoblasts failed to induce NFATc1 and osteoclast marker genes in macrophages.
• Impaired osteoclastogenesis was observed when bone marrow macrophages were treated with conditioned medium from shPP2A cells.

Conclusions:

• Alteration of PP2A Cα expression in osteoblasts significantly modulates RANKL and OPG expression.
• These modulations in RANKL and OPG are critical in regulating osteoclast differentiation via the NFATc1 transcription factor.
• PP2A Cα in osteoblasts plays a key role in the intricate process of osteoclastogenesis and bone remodeling.